Hudock Inc’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Hudock Inc’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-125	Closed	-$12K	–	637
2015 Q1	$12K	Sell	125 -75	-38%	-$7.94K	0.01%	413
2014 Q4	$19K	Hold	200	–	–	0.01%	330
2014 Q3	$14K	Hold	200	–	–	0.01%	358
2014 Q2	$21K	Buy	+200	New	+$17K	0.02%	326

Hudock Inc's GEVA Position: Q2 2015 in Review

Hudock Inc sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 125 shares — an estimated $12K sold.

Hudock Inc first reported a position in GEVA in Q2 2014 and held it in 4 quarters. The position peaked at $21K in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Hudock Inc reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Hudock Inc sold 125 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $12K.
Hudock Inc first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2014 and held it in 4 quarters.
Hudock Inc's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $21K in Q2 2014.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Hudock Inc's 13F filing for Q2 2015, filed 13 Aug 2015.